Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients having clinical signs and symptoms of Vatrakta such as Sandhi shula/Toda (Pain), Sandhi Shotha (swelling), Sparshaashatva (Tenderness), Chimichimayan (tingling sensation),team vaivarnya (Discoloration Of skin). Age group having 20 to 65 years irrespective of religion, gender, socioeconomic status. Patient having serum uric acid more than 7 mg/dl in male and more than 6mg/dl in female.
Exclusion criteria
Exclusion criteria: Known case of Amavata, Sandhigata vata, SLE, Renal Disease Known case of tuberculosis of any system Chronic joint deformity Hypersensitive reaction to any drug Pregnancy Patients with chronic major illness High risk (above 65 yrs age,known cases of HTN,DM,COPD),Comorbid patients Suspected for Covid-19. Suspected Covid-19 patients having symptoms as per ICMR guidelines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Aatarushadi Kwath Ghan Vati 500mg two times a day after meal with lukewarm water and Kaishore Guggul 500mg two times a day after meal with lukewarm water in the management of Vatarakta (Gout) with reference to increase Serum uric acid level within 45 daysTimepoint: 45 days with follow up on 15th , 30th , 45th day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare and study the efficacy of Aatarushadi Kwath Ghan Vati 2. To compare and study the efficacy of Kaishore Guggul 3.To study the adverse effects if anyTimepoint: 45 days with follow up on 15th , 30th , 45th day | — |
Countries
India
Contacts
PDEAS college of ayurved and research center pradhikaran nigdi pune